Bay Colony Advisors’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-36,090
Closed -$639K 515
2025
Q2
$639K Buy
36,090
+7,512
+26% +$146K 0.09% 203
2025
Q1
$590K Buy
+28,578
New +$542K 0.09% 216
2023
Q3
Sell
-56,489
Closed -$1.06M 353
2023
Q2
$1.06M Buy
+56,489
New +$1.14M 0.26% 89

Other funds holding BTAL

Bay Colony Advisors's BTAL Position: Q3 2025 in Review

Bay Colony Advisors sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q3 2025, closing a stake of 36,090 shares — an estimated $639K sold.

Bay Colony Advisors first reported a position in BTAL in Q2 2023 and held it in 3 quarters. The position peaked at $1.06M in Q2 2023. 71 funds tracked by Wall St. Rank hold BTAL as of Q3 2025.

  • Bay Colony Advisors reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q3 2025 after selling out during the quarter.
  • Bay Colony Advisors sold 36,090 AGF US Market Neutral Anti-Beta Fund shares in Q3 2025, an estimated $639K.
  • Bay Colony Advisors first reported a position in AGF US Market Neutral Anti-Beta Fund in Q2 2023 and held it in 3 quarters.
  • Bay Colony Advisors's AGF US Market Neutral Anti-Beta Fund position peaked at $1.06M in Q2 2023.
  • 71 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q3 2025.

Based on Bay Colony Advisors's 13F filing for Q3 2025, filed 24 Oct 2025.